Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera

Carlos J. Sanchez, Brady J. Hurtgen, Anel Lizcano, Pooja Shivshankar, Garry T. Cole, Carlos J. Orihuela

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Streptococcus pneumoniae (the pneumococcus) is the leading cause of otitis media, community-acquired pneumonia (CAP), sepsis, and meningitis. It is now evident that S. pneumoniae forms biofilms during nasopharyngeal colonization; the former which facilitates persistence, the latter, a prerequisite for subsequent development of invasive disease. Proteomic evaluation of S. pneumoniae suggests the antigen profile available for host-recognition is altered as a consequence of biofilm growth. This has potentially meaningful implications in regards to adaptive immunity and protection from disseminated disease. We therefore examined the antigen profile of biofilm and planktonic pneumococcal cell lysates, tested their reactivity with human convalescent sera and that generated against biofilm pneumococci, and examined whether immunization with biofilm pneumococci protected mice against infectious challenge. Results: Biofilm pneumococci have dramatically altered protein profiles versus their planktonic counterparts. During invasive disease the humoral immune response is skewed towards the planktonic protein profile. Immunization with biofilm bacteria does not elicit a strong-cross-reactive humoral response against planktonic bacteria nor confer resistance against challenge with a virulent isolate from another serotype. We identified numerous proteins, including Pneumococcal serine-rich repeat protein (PsrP), which may serve as a protective antigens against both colonization and invasive disease. Conclusion: Differential protein production by planktonic and biofilm pneumococci provides a potential explanation for why individuals remain susceptible to invasive disease despite previous colonization events. These findings also strongly suggest that differential protein production during colonization and disease be considered during the selection of antigens for any future protein vaccine.

Original languageEnglish (US)
Article number245
JournalBMC Microbiology
Volume11
DOIs
StatePublished - 2011

Fingerprint

Biofilms
Streptococcus pneumoniae
Serum
Proteins
Antigens
Immunization
Bacteria
Otitis Media
Adaptive Immunity
Humoral Immunity
Meningitis
Proteomics
Serine
Sepsis
Pneumonia
Vaccines
Growth

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Sanchez, C. J., Hurtgen, B. J., Lizcano, A., Shivshankar, P., Cole, G. T., & Orihuela, C. J. (2011). Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. BMC Microbiology, 11, [245]. https://doi.org/10.1186/1471-2180-11-245

Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. / Sanchez, Carlos J.; Hurtgen, Brady J.; Lizcano, Anel; Shivshankar, Pooja; Cole, Garry T.; Orihuela, Carlos J.

In: BMC Microbiology, Vol. 11, 245, 2011.

Research output: Contribution to journalArticle

Sanchez, CJ, Hurtgen, BJ, Lizcano, A, Shivshankar, P, Cole, GT & Orihuela, CJ 2011, 'Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera', BMC Microbiology, vol. 11, 245. https://doi.org/10.1186/1471-2180-11-245
Sanchez, Carlos J. ; Hurtgen, Brady J. ; Lizcano, Anel ; Shivshankar, Pooja ; Cole, Garry T. ; Orihuela, Carlos J. / Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. In: BMC Microbiology. 2011 ; Vol. 11.
@article{8ebc6a5229c045c9a9a33ba096a603b0,
title = "Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera",
abstract = "Background: Streptococcus pneumoniae (the pneumococcus) is the leading cause of otitis media, community-acquired pneumonia (CAP), sepsis, and meningitis. It is now evident that S. pneumoniae forms biofilms during nasopharyngeal colonization; the former which facilitates persistence, the latter, a prerequisite for subsequent development of invasive disease. Proteomic evaluation of S. pneumoniae suggests the antigen profile available for host-recognition is altered as a consequence of biofilm growth. This has potentially meaningful implications in regards to adaptive immunity and protection from disseminated disease. We therefore examined the antigen profile of biofilm and planktonic pneumococcal cell lysates, tested their reactivity with human convalescent sera and that generated against biofilm pneumococci, and examined whether immunization with biofilm pneumococci protected mice against infectious challenge. Results: Biofilm pneumococci have dramatically altered protein profiles versus their planktonic counterparts. During invasive disease the humoral immune response is skewed towards the planktonic protein profile. Immunization with biofilm bacteria does not elicit a strong-cross-reactive humoral response against planktonic bacteria nor confer resistance against challenge with a virulent isolate from another serotype. We identified numerous proteins, including Pneumococcal serine-rich repeat protein (PsrP), which may serve as a protective antigens against both colonization and invasive disease. Conclusion: Differential protein production by planktonic and biofilm pneumococci provides a potential explanation for why individuals remain susceptible to invasive disease despite previous colonization events. These findings also strongly suggest that differential protein production during colonization and disease be considered during the selection of antigens for any future protein vaccine.",
author = "Sanchez, {Carlos J.} and Hurtgen, {Brady J.} and Anel Lizcano and Pooja Shivshankar and Cole, {Garry T.} and Orihuela, {Carlos J.}",
year = "2011",
doi = "10.1186/1471-2180-11-245",
language = "English (US)",
volume = "11",
journal = "BMC Microbiology",
issn = "1471-2180",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera

AU - Sanchez, Carlos J.

AU - Hurtgen, Brady J.

AU - Lizcano, Anel

AU - Shivshankar, Pooja

AU - Cole, Garry T.

AU - Orihuela, Carlos J.

PY - 2011

Y1 - 2011

N2 - Background: Streptococcus pneumoniae (the pneumococcus) is the leading cause of otitis media, community-acquired pneumonia (CAP), sepsis, and meningitis. It is now evident that S. pneumoniae forms biofilms during nasopharyngeal colonization; the former which facilitates persistence, the latter, a prerequisite for subsequent development of invasive disease. Proteomic evaluation of S. pneumoniae suggests the antigen profile available for host-recognition is altered as a consequence of biofilm growth. This has potentially meaningful implications in regards to adaptive immunity and protection from disseminated disease. We therefore examined the antigen profile of biofilm and planktonic pneumococcal cell lysates, tested their reactivity with human convalescent sera and that generated against biofilm pneumococci, and examined whether immunization with biofilm pneumococci protected mice against infectious challenge. Results: Biofilm pneumococci have dramatically altered protein profiles versus their planktonic counterparts. During invasive disease the humoral immune response is skewed towards the planktonic protein profile. Immunization with biofilm bacteria does not elicit a strong-cross-reactive humoral response against planktonic bacteria nor confer resistance against challenge with a virulent isolate from another serotype. We identified numerous proteins, including Pneumococcal serine-rich repeat protein (PsrP), which may serve as a protective antigens against both colonization and invasive disease. Conclusion: Differential protein production by planktonic and biofilm pneumococci provides a potential explanation for why individuals remain susceptible to invasive disease despite previous colonization events. These findings also strongly suggest that differential protein production during colonization and disease be considered during the selection of antigens for any future protein vaccine.

AB - Background: Streptococcus pneumoniae (the pneumococcus) is the leading cause of otitis media, community-acquired pneumonia (CAP), sepsis, and meningitis. It is now evident that S. pneumoniae forms biofilms during nasopharyngeal colonization; the former which facilitates persistence, the latter, a prerequisite for subsequent development of invasive disease. Proteomic evaluation of S. pneumoniae suggests the antigen profile available for host-recognition is altered as a consequence of biofilm growth. This has potentially meaningful implications in regards to adaptive immunity and protection from disseminated disease. We therefore examined the antigen profile of biofilm and planktonic pneumococcal cell lysates, tested their reactivity with human convalescent sera and that generated against biofilm pneumococci, and examined whether immunization with biofilm pneumococci protected mice against infectious challenge. Results: Biofilm pneumococci have dramatically altered protein profiles versus their planktonic counterparts. During invasive disease the humoral immune response is skewed towards the planktonic protein profile. Immunization with biofilm bacteria does not elicit a strong-cross-reactive humoral response against planktonic bacteria nor confer resistance against challenge with a virulent isolate from another serotype. We identified numerous proteins, including Pneumococcal serine-rich repeat protein (PsrP), which may serve as a protective antigens against both colonization and invasive disease. Conclusion: Differential protein production by planktonic and biofilm pneumococci provides a potential explanation for why individuals remain susceptible to invasive disease despite previous colonization events. These findings also strongly suggest that differential protein production during colonization and disease be considered during the selection of antigens for any future protein vaccine.

UR - http://www.scopus.com/inward/record.url?scp=80055118611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055118611&partnerID=8YFLogxK

U2 - 10.1186/1471-2180-11-245

DO - 10.1186/1471-2180-11-245

M3 - Article

C2 - 22047041

AN - SCOPUS:80055118611

VL - 11

JO - BMC Microbiology

JF - BMC Microbiology

SN - 1471-2180

M1 - 245

ER -